Celltrion
068270.KS
₹11,222
Share price
0.11%
Change (1 day)
-7.00%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total assets
Total assets on the balance sheet as of March 2025 : ₹1.239 Trillion
According to Celltrion 's latest financial reports the company's total assets are ₹1.239 Trillion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Celltrion - Total assets on balance sheet (from 2007 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | ₹1.230 T | -4.16% |
| 2023-12-31 | ₹1.284 T | 232.18% |
| 2022-12-31 | ₹386.65 B | 8.94% |
| 2021-12-31 | ₹354.93 B | 5.03% |
| 2020-12-31 | ₹337.93 B | 41.98% |
| 2019-12-31 | ₹238.02 B | 8.47% |
| 2018-12-31 | ₹219.42 B | 11.22% |
| 2017-12-31 | ₹197.29 B | 21.36% |
| 2016-12-31 | ₹162.57 B | 8.87% |
| 2015-12-31 | ₹149.32 B | 11.12% |
| 2014-12-31 | ₹134.38 B | 15.91% |
| 2013-12-31 | ₹115.93 B | 26.85% |
| 2012-12-31 | ₹91.39 B | 42.34% |
| 2011-12-31 | ₹64.21 B | 39.78% |
| 2010-12-31 | ₹45.93 B | 103.79% |
| 2009-12-31 | ₹22.54 B | 16.68% |
| 2008-12-31 | ₹19.31 B | 641.94% |
| 2007-12-31 | ₹2.60 B |